PCM
BRLI

Palouse Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Palouse Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,245
Closed -$339K – 133
2014
Q1 		$339K Sell
12,245
-585
-5% -$15.3K 0.13% 93
2013
Q4 		$328K Sell
12,830
-170
-1% -$5.24K 0.13% 97
2013
Q3 		$388K Sell
13,000
-90
-0.7% -$2.5K 0.16% 83
2013
Q2 		$376K Buy
+13,090
New +$361K 0.16% 76

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Palouse Capital Management's BRLI Position: Q2 2014 in Review

Palouse Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2014, closing a stake of 12,245 shares — an estimated $339K sold.

Palouse Capital Management first reported a position in BRLI in Q2 2013 and held it in 4 quarters. The position peaked at $388K in Q3 2013. 168 funds tracked by Wall St. Rank hold BRLI as of Q2 2014.

  • Palouse Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2014 after selling out during the quarter.
  • Palouse Capital Management sold 12,245 BIO-REFERENCE LABS INC-NEW- shares in Q2 2014, an estimated $339K.
  • Palouse Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 4 quarters.
  • Palouse Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $388K in Q3 2013.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2014.

Based on Palouse Capital Management's 13F filing for Q2 2014, filed 1 Aug 2014.